US-based Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions.
The launch marks an expansion of Stryker’s solutions for foot and ankle surgeons treating injuries commonly resulting from sports trauma and ankle fractures, with a focus on options for both adult and adolescent patients.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Synchfix EVT builds on the previous Synchfix platform and introduces design improvements to minimise procedural complexity compared to prior devices.
The device integrates suture tensioning handles within implant instrumentation, featuring an ergonomic, single-handed handle design and a low-profile titanium medial implant.
The all-in-one system aims to provide a streamlined user experience for surgeons during implantation. It is indicated for bone fixation and soft tissue in cases of ankle syndesmosis disruptions, with or without associated fractures.
It can also be used as an adjunct in managing ankle fractures such as Weber B, Weber C, and Maisonneuve types in adult and adolescent populations.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataFurthermore, the system is said to be the first flexible syndesmotic fixation device available for use in adolescents, broadening treatment options for younger patients.
Stryker vice-president and foot and ankle general manager Adam Jacobs said: “Stryker is dedicated to helping foot and ankle surgeons treat their patients more efficiently while enhancing patient care and the overall healthcare experience.
“Synchfix EVT reflects our commitment to delivering next-generation solutions in soft tissue by designing technologies that help surgeons work more efficiently while keeping patient care and safety at the centre.
“At Stryker, we’re continually energised by our customers’ commitment to their patients. Synchfix EVT demonstrates how listening to their needs helps shape meaningful design and procedural advancements.”
The company is presenting Synchfix EVT at the American College of Foot and Ankle Surgeons Annual Scientific Conference, offering demonstrations that emphasise its sterile, single-use, knotless, and flexible suture-button system developed for stabilising syndesmotic ankle injuries.
Last month, Stryker reported an 11.2% rise in revenue for 2025, attributed to significant growth within its vascular segment.
